Up-modulation of PLC-β2 reduces the number and malignancy of triple-negative breast tumor cells with a CD133+/EpCAM+ phenotype: a promising target for preventing progression of TNBC

Peer Review reports

Original Submission
17 Nov 2016	Submitted	Original manuscript
3 Mar 2017	Reviewed	Reviewer Report - Samantha Oakes
23 Apr 2017	Reviewed	Reviewer Report - Sushanta Banerjee
25 Jul 2017	Author responded	Author comments - Federica Brugnoli
Resubmission - Version 2
25 Jul 2017	Submitted	Manuscript version 2
25 Jul 2017	Reviewed	Reviewer Report - Sushanta Banerjee
11 Aug 2017	Reviewed	Reviewer Report - Samantha Oakes
21 Aug 2017	Author responded	Author comments - Federica Brugnoli
Resubmission - Version 3
21 Aug 2017	Submitted	Manuscript version 3
Publishing
22 Aug 2017	Editorially accepted
4 Sep 2017	Article published	10.1186/s12885-017-3592-y

Back to article page